课题基金 / 基金详情

项目摘要

项目成果

JEFFREY S FRIEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to characterize that subset of the proteome possessing a particular type of post-translational modification protein carbonyls that has been associated with diverse pathologies including inflammatory conditions, neurodegenerative diseases, aging and anemia. Our goal is to develop improved reagents and techniques for study of the role of protein carbonylation in cellular physiology in both normal and pathologic states. Improved technical ability will facilitate investigation of a number of basic questions regarding protein oxidation: What is the hierarchy of protein oxidation -- are there specific proteins that are carbonylated first, which serve as a buffer against oxidative insult? Carbonylated proteins are subject to degradation in the proteasome --does degradation of `carbonyl sensor' proteins activate cellular responses to oxidative damage? Are there distinct signatures or patterns of protein oxidation that are disease specific? If so, can these patterns provide useful diagnostic or prognostic information? In this proposal we will use an established mouse model of Sideroblastic Anemia (SA), in which protein carbonyls are significantly elevated, as substrate for the development and validation of novel techniques for the enrichment, quantification and identification of proteins possessing this type of oxidative lesion. We will then use these methods in the analysis of purified sideroblasts (iron loaded cells characteristic of this disorder) isolated from clinical specimens of patients with SA. We present a novel method for purification of these iron loaded cells from patient samples that will facilitate these studies. Analysis of oxidized proteins will employ affinity purification, differential gel analysis (DIGE) and mass spectrometry to define the oxidized proteome in both the mouse model and clinical specimens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
  • 批准号:
    7654467
  • 项目类别:
  • 资助金额:
    $47.48万
  • 财政年份:
    2009
  • 负责人:
    JEFFREY S FRIEDMAN
  • 依托单位:
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
  • 批准号:
    7934640
  • 项目类别:
  • 资助金额:
    $47.48万
  • 财政年份:
    2009
  • 负责人:
    JEFFREY S FRIEDMAN
  • 依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
  • 批准号:
    7591099
  • 项目类别:
  • 资助金额:
    $23.74万
  • 财政年份:
    2008
  • 负责人:
    JEFFREY S FRIEDMAN
  • 依托单位:
Anemia in the Elderly: Pathogenesis
  • 批准号:
    7407984
  • 项目类别:
  • 资助金额:
    $38.07万
  • 财政年份:
    2007
  • 负责人:
    JEFFREY S FRIEDMAN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: